Copyright © 2019. Inderes Oy. All rights reserved.
Orion
7730 investors follow this company
BUY 45.84 LOWEST 45.09 VOLUME 613 190
SELL 45.90 HIGHEST 46.84 VALUE 28,271 Milj. EUR

Would you like to see our recommendations and target prices?

You already have an Inderes account? Log in from here.

Analyytikko

Petri Kajaani
+358 50 527 8680

Upcoming events

17
Jul
Osavuosikatsaukset

Latest insider trading

Net impact profile

Type: stock_exchange_release
8.7.
2020

ORION CORPORATION STOCK EXCHANGE RELEASE INSIDE INFORMATION  8 JULY 2020 at 19.00 EEST             
         

Orion upgrades full-year outlook for 2020

Orion Corporation upgrades the full-year outlook for 2020, provided on 24 April 2020, for the part regarding operating profit. In 2020, the operating profit is estimated to be slightly higher or higher than in 2019.

Type: stock_exchange_release
26.6.
2020

ORION CORPORATION PRESS RELEASE 26 JUNE 2020 at 14.40 EEST             
         
Orion publishes Half-Year Financial Report for January-June 2020 on Friday 17 July 2020

Type: stock_exchange_release
26.6.
2020

ORION CORPORATION PRESS RELEASE 26 JUNE 2020 at 9.45 EEST             
         
Distribution of Zoetis’ products in Sweden, Denmark and Norway by Orion to end after 2020

Zoetis has announced that the company will establish its own sales and marketing activities in Denmark, Norway and Sweden. In consequence, Orion Pharma Animal Health, a part of Orion Group, will cease sales and distribution of Zoetis products in these countries after 31 December 2020.

Type: stock_exchange_release
25.6.
2020

ORION CORPORATION STOCK EXCHANGE RELEASE 25 JUNE 2020 at 8.30 EEST             
         

The cancellation of Orion Corporation shares entered in the Trade Register

The cancellation of 63,650 Orion Corporation A shares and 59,900 B shares has today on 25 June 2020 been entered in the Trade Register. The cancellation reduces the number of Orion A and B shares with the corresponding amounts but has no effect on the share capital. The Board of Directors of Orion Corporation decided on the share cancellation on 15 June 2020.

Type: stock_exchange_release
15.6.
2020

ORION CORPORATION STOCK EXCHANGE RELEASE 15 JUNE 2020 at 15.45 EEST             
         

Orion Corporation has decided on cancellation of shares on the joint account

Type: stock_exchange_release
12.6.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 12 June 2020 at 17.00 EEST

Orion Corporation: Managers’ transactions – Lehtoranta, Ari

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
12.6.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 12 June 2020 at 17.00 EETS

Orion Corporation: Managers’ transactions – Pia Kalsta

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
12.6.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 12th June 2020 at 17.00 EEST

Orion Corporation: Managers’ transactions – Hilpi Rautelin

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
12.6.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 12th June 2020 at 17.00 EEST

Orion Corporation: Managers’ transactions – Eija Ronkainen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
12.6.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 12th June 2020 at 17.00 EEST

Orion Corporation: Managers’ transactions – Kari Jussi Aho

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion

Orion lyhyesti

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.